Xperix

317770 · KOSDAQ · ₩317770 · 엑스페릭스

₩2,435▲ ₩45 (1.88%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −36.75%
Market cap
₩90B
Enterprise value
₩107B
P/E
258.5×
P/B
1.0×
Dividend yield
0.0%
ROE
0.4%
Net margin
1.4%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−48.6% from the high

₩2,010Today: ₩2,390 – ₩2,460₩4,735

Returns

  • 1W−4.3%
  • 1M−7.8%
  • 3M−2.6%
  • 6M−33.5%
  • YTD−12.9%
  • 1Y−36.8%
Volume today
60,959
0.4× the 20-day average
Traded today
₩148M
Listed shares
36,997,002
EPS (12 months)
₩9
Earnings yield 0.4%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

31Quiet
  • BuzzQuietBuzz 31 of 100 (50 is a normal day for this stock).
  • MomentumWeak-7.6% over the last month; the price is below its 20-day average.
  • News impactSome6 news items and filings in two weeks; 0 rated high impact, 2 medium.

Signals describe activity, not recommendations. Not financial advice.

Xperix stock overview

Xperix (엑스페릭스, KRX: 317770) is listed on KOSDAQ, in the Electronic components sector. The company develops, manufactures and sells its own biometric devices and solutions used to register, authenticate and use biometric data. Its shares closed at ₩2,435 on Oct 27, 2026, up 1.88% on the day, giving it a market value of ₩90B.

Key facts

Market cap
₩90B
Sector
Electronic components
Latest price change
+1.88%
As of
Oct 27, 2026
Main business
The company develops, manufactures and sells its own biometric devices and solutions used to register, authenticate and use biometric data.

Quick answers about Xperix

What does Xperix do?
The company develops, manufactures and sells its own biometric devices and solutions used to register, authenticate and use biometric data. Its main business segments are Biometric Solutions, which includes fingerprint enrollment and fingerprint authentication devices, and eDocument Solutions, which includes passport readers and fingerprint scanners. Its products are used for border control, eID systems and electronic passport issuance, and it sells in markets including India, Europe, Asia and Africa, mostly through system integrators, OEM manufacturers and solution providers to public and private customers.
What is the market cap of Xperix?
The market capitalisation of Xperix was ₩90B at the close on Oct 27, 2026.
Who are the largest shareholders of Xperix?
According to the latest official filings, the largest reported holders are Yoon Sang-chul (19.21%, as of Sep 21, 2026); Gluon Bond Discretionary Investment (4.66%, as of Apr 23, 2025); VM Asset Management (4.46%, as of May 20, 2025).
When is the next earnings report from Xperix?
Korean companies rarely announce results dates in advance. Based on when Xperix filed the same report in past years, its next 3q results is expected around Nov 14, 2026.

Company profile

The company develops, manufactures and sells its own biometric devices and solutions used to register, authenticate and use biometric data. Its main business segments are Biometric Solutions, which includes fingerprint enrollment and fingerprint authentication devices, and eDocument Solutions, which includes passport readers and fingerprint scanners. Its products are used for border control, eID systems and electronic passport issuance, and it sells in markets including India, Europe, Asia and Africa, mostly through system integrators, OEM manufacturers and solution providers to public and private customers.

Written by AI from the company's latest annual report.

Korean name
엑스페릭스
CEO
윤상철
Founded
Apr 2017
Listed
Aug 2019
Listed shares
36,997,002
Fiscal year ends
Month 12

Similar companies

Recent news

News · Chosun Biz·

[MM] Xperex Struggles to Sell Subsidiary Stake; Chairman Koo Bon-ho Also Exits

Predicted impact: Low· Actual: −4.3% vs sector, volume 0.4× normal (5 trading days)

Struggling subsidiary stake sale; company market value is small, deal size not given.

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Xperix / 엑스페릭스 / 317770 / KRX:317770

Source: KRX statistical information